Sodium Butyrate as a Histone Deacetylase Inhibitor Affects Toll-Like Receptor 4 Expression in Colorectal Cancer Cell Lines

References

• Abaza MSI, Bahman AM, Al-Attiyah RJ, Kollamparambil AM. (2012). Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action. Tumor Biol, 33(6), 1951–1972.
   PubMedGoogle Scholar
• Asarat M, Apostolopoulos V, Vasiljevic T, Donkor O. (2016). Short-chain fatty acids regulate cytokines and Th17/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol Invest, 45(3), 205–222. doi:10.3109/08820139.2015.1122613.
   PubMed Web of Science ®Google Scholar
• Asarat M, Vasiljevic T, Apostolopoulos V, Donkor O. (2015). Short-chain fatty acids regulate secretion of IL-8 from human intestinal epithelial cell lines in vitro. Immunol Invest, 44(7), 678–693. doi:10.3109/08820139.2015.1085389.
   PubMed Web of Science ®Google Scholar
• Bardhan K, Paschall AV, Yang D, et al. (2015). IFNγ Induces DNA Methylation–silenced GPR109A expression via pSTAT1/p300 and H3K18 acetylation in colon cancer. Cancer Immunol Res, 3(7), 795–805. doi:10.1158/2326-6066.CIR-14-0164.
   PubMed Web of Science ®Google Scholar
• Basith S, Manavalan B, Yoo TH, et al. (2012). Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res, 35(8), 1297–1316. doi:10.1007/s12272-012-0802-7.
   PubMed Web of Science ®Google Scholar
• Berni Canani R, Di Costanzo M, Leone L. (2012). The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenet, 4(1), 4. doi:10.1186/1868-7083-4-4.
   PubMed Web of Science ®Google Scholar
• Bode KA, Dalpke AH. (2011). HDAC inhibitors block innate immunity. Blood, 117(4), 1102–1103. doi:10.1182/blood-2010-11-315820.
   PubMed Web of Science ®Google Scholar
• Daroqui MC, Augenlicht LH. (2010). Transcriptional attenuation in colon carcinoma cells in response to butyrate. Cancer Prev Res, 3(10), 1292–1302. doi:10.1158/1940-6207.CAPR-10-0083.
   PubMed Web of Science ®Google Scholar
• Dell‘Aversana C, Lepore I, Altucci L. (2012). HDAC modulation and cell death in the clinic. Exp Cell Res, 318(11), 1229–1244. doi:10.1016/j.yexcr.2012.01.025.
   PubMed Web of Science ®Google Scholar
• Doan HQ, Bowen KA, Jackson LA, Mark Evers B. (2009). Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. Anticancer Res, 29(7), 2473–2478.
   PubMed Web of Science ®Google Scholar
• Dokmanovic M, Clarke C, Marks PA. (2007). Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res, 5(10), 981–989. doi:10.1158/1541-7786.MCR-07-0324.
   PubMed Web of Science ®Google Scholar
• Forgione N, Tropepe V. (2012). Toll-like signaling and the cytokine IL-6 regulate histone deacetylase dependent neuronal survival. PLoS One, 7(7), e41033. doi:10.1371/journal.pone.0041033.
   PubMed Web of Science ®Google Scholar
• Fukata M, Hernandez Y, Conduah D, et al. (2009). Innate immune signaling by Toll‐like receptor‐4 (TLR4) shapes the inflammatory microenvironment in colitis‐associated tumors. Inflamm Bowel Dis, 15(7), 997–1006. doi:10.1002/ibd.20880.
   PubMed Web of Science ®Google Scholar
• Garrett WS. (2015). Cancer and the microbiota. Science, 348(6230), 80–86. doi:10.1126/science.aaa4972.
   PubMed Web of Science ®Google Scholar
• Gupta KD, Shakespear MR, Iyer A, et al. (2016). Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases. Clin Transl Immunol, 5(1), e62. doi:10.1038/cti.2015.46.
   PubMed Web of Science ®Google Scholar
• Hague A, Manning AM, Hanlon KA, et al. (1993). Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53‐independent pathway: implications for the possible role of dietary fibre in the prevention of large‐bowel cancer. Int J Cancer, 55(3), 498–505.
   PubMed Web of Science ®Google Scholar
• Hinnebusch BF, Meng S, Wu JT, et al. (2002). The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr, 132(5), 1012–1017. doi:10.1093/jn/132.5.1012.
   PubMed Web of Science ®Google Scholar
• Irrazábal T, Belcheva A, Girardin SE, et al. (2014). The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell, 54(2), 309–320. doi:10.1016/j.molcel.2014.03.039.
   PubMed Web of Science ®Google Scholar
• Joseph J, Mudduluru G, Antony S, et al. (2004). Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene, 23(37), 6304–6315. doi:10.1038/sj.onc.1207852.
   PubMed Web of Science ®Google Scholar
• Kroesen M, Gielen P, Brok IC, et al. (2014). “HDAC inhibitors and immunotherapy; a double edged sword?”. Oncotarget, 5(16), 6558. doi:10.18632/oncotarget.2289.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen H. (2012). Silencing of Wnt5a during colon cancer metastasis involves histone modifications. Epigenetics, 7(6), 551–558. doi:10.4161/epi.20050.
   PubMed Web of Science ®Google Scholar
• Link A, Balaguer F, Goel A. (2010). Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol, 80(12), 1771–1792. doi:10.1016/j.bcp.2010.06.036.
   PubMed Web of Science ®Google Scholar
• Ma W, Stafford LJ, Dali L, et al. (2007). GCIP/CCNDBP1, a helix–loop–helix protein, suppresses tumorigenesis. J Cell Biochem, 100(6), 1376–1386. doi:10.1002/jcb.21140.
   PubMed Web of Science ®Google Scholar
• Min XIAO, Liu YG, Zou MC, Fei ZOU. (2014). Sodium butyrate induces apoptosis of human colon cancer cells by modulating ERK and sphingosine kinase 2. Biomed Environ Sci, 27(3), 197–203. doi:10.3967/bes2014.040.
   PubMed Web of Science ®Google Scholar
• Omrane I, Baroudi O, Kourda N, et al. (2014). Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis. Tumor Biol, 35(1), 545. doi:10.1007/s13277-013-1075-6.
   PubMedGoogle Scholar
• Pfaffl MW, Horgan GW, Dempfle L. (2002). Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 30(9), e36–e. doi:10.1093/nar/30.9.e36.
   PubMed Web of Science ®Google Scholar
• Puglisi MA, Barba M, Corbi M, et al. (2011). Identification of Endothelin‐1 and NR4A2 as CD133‐regulated genes in colon cancer cells. J Pathol, 225(2), 305–314. doi:10.1002/path.2954.
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhitov R. (2009). Toll-like receptors and cancer. Nat Rev Cancer, 9(1), 57–63. doi:10.1038/nrc2541.
   PubMed Web of Science ®Google Scholar
• Ramakers C, Ruijter JM, Lekanne Deprez RH, Moorman AFM. (2003). Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett, 339(1), 62–66.
   PubMed Web of Science ®Google Scholar
• Ruijter JM, Ramakers C, Hoogaars WMH, et al. (2009). Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res, 37(6), e45–e. doi:10.1093/nar/gkp045.
   PubMed Web of Science ®Google Scholar
• Säemann MD, Böhmig GA, Österreicher CH, et al. (2000). Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J, 14(15), 2380–2382. doi:10.1096/fj.00-0359fje.
   PubMed Web of Science ®Google Scholar
• Sato Y, Goto Y, Narita N, Hoon DSB. (2009). Cancer cells expressing toll-like receptors and the tumor microenvironment. Cancer Microenviron, 2, 205–214. doi:10.1007/s12307-009-0022-y.
   PubMedGoogle Scholar
• Sears CL, Garrett WS. (2014). Microbes, microbiota, and colon cancer. Cell Host Microbe, 15(3), 317–328. doi:10.1016/j.chom.2014.02.007.
   PubMed Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. (2010). Epigenetics in cancer. Carcinogenesis, 31(1), 27–36. doi:10.1093/carcin/bgp220.
   PubMed Web of Science ®Google Scholar
• Suh HS, Choi S, Khattar P, et al. (2010). Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. J Neuroimmune Pharmacol, 5(4), 521–532. doi:10.1007/s11481-010-9192-0.
   PubMed Web of Science ®Google Scholar
• Tabuchi Y, Takasaki I, Ishii Y, et al. (2006). Genetic networks responsive to sodium butyrate in colonic epithelial cells. FEBS Lett, 580(13), 3035–3041. doi:10.1016/j.febslet.2006.04.048.
   PubMed Web of Science ®Google Scholar
• Terova G, Diaz N, Rimoldi S, et al. (2016). Effects of sodium butyrate treatment on histone modifications and the expression of genes related to epigenetic regulatory mechanisms and immune response in European Sea Bass (Dicentrarchus Labrax) fed a plant-based diet. PLoS One, 11(7), e0160332. doi:10.1371/journal.pone.0160332.
   PubMed Web of Science ®Google Scholar
• Wakabayashi K, Saito H, Kaneko F, et al. (2005). Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor. Int J Oncol, 26(1), 233–239.
   PubMed Web of Science ®Google Scholar
• Waldecker M, Kautenburger T, Daumann H, et al. (2008). Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem, 19(9), 587–593. doi:10.1016/j.jnutbio.2007.08.002.
   PubMed Web of Science ®Google Scholar
• Wang X, Jackson LN, Johnson SM, et al. (2010). Suppression of neurotensin receptor type 1 expression and function by histone deacetylase inhibitors in human colorectal cancers. Mol Cancer Ther, 9(8), 2389–2398. doi:10.1158/1535-7163.MCT-09-1080.
   PubMed Web of Science ®Google Scholar
• Wu S, Li RW, Weizhong L, Cong-Jun L. (2012). Transcriptome characterization by RNA-seq unravels the mechanisms of butyrate-induced epigenomic regulation in bovine cells. PLoS One, 7(5), e36940. doi:10.1371/journal.pone.0036940.
   PubMed Web of Science ®Google Scholar
• Yesudhas D, Gosu V, Anwar MA, Choi S. (2014). Multiple roles of toll-like receptor 4 in colorectal cancer. Front Immunol, 5, 334. doi:10.3389/fimmu.2014.00334.
   PubMed Web of Science ®Google Scholar
• Youn H-S, Lim HJ, Lee HJ, et al. (2008). Garlic (Allium sativum) extract inhibits lipopolysaccharide-induced Toll-like receptor 4 dimerization. Biosci Biotechnol Biochem, 72(2), 368–375. doi:10.1271/bbb.70434.
   PubMed Web of Science ®Google Scholar